FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022356742> ?p ?o ?g. }

• W2022356742 endingPage "199" @default.
• W2022356742 startingPage "194" @default.
• W2022356742 abstract "Incidence and mortality of human malignant melanoma has risen rapidly over recent decades. Although the notorious resistance to treatment is characteristic for metastatic malignant melanoma, only a few experimental models have been established to study the metastatic cascade or to test new alternative treatment modalities. Thus, new human models are wanted. Here, we describe the metastatic behaviour of seven human melanoma cell lines derived from two primary cutaneous melanomas (WM 98-1, WM 1341) and five metastases established from liver (UKRV-Mel-4), skin (M7, M13), pleural effusion (UKRV-Mel-2) and lymph node (MV3). All cell lines were analysed for their capacity to grow in nude mice after s.c. and i.v. administration. M13 cells developed liver metastases spontaneously after s.c. injection, and subsequent passages of M13 and M7 melanoma cells caused liver metastases after i.v. injection, whereas MV3 and WM98-1 gave rise to lung metastases, using the same inoculation route. In contrast, WM 1341, UKRV-Mel-2 and UKRV-Mel-4 grew only very slowly in nude mice after s.c. injection and did not cause any metastases after i.v. or s.c. administration. The pattern of metastases or growth kinetics did not correlate with the interleukin 8 or tumour necrosis factor secretion of cell lines. Adhesion molecules and growth factor receptor expression on the cell lines differed widely, as determined by flow cytometry, with the low metastatic cell lines (UKRV-Mel-2, UKRV-Mel-4 and WM 1341) demonstrating a marked reduction in VLA-1 and VLA-5 expression compared with the metastatic lines (M7, M13, MV3 and WM 98-1). Expression of pigment-related proteins such as tyrosinase, TRP-1, TRP-2, Melan-A/MART-1, gp100, MAGE1 or MAGE-3 was not associated with growth and metastatic characteristics of the melanoma cell lines analysed. In conclusion, the established human melanoma cell lines exhibited diverse growth behaviour in nude mice in congruence with some early established prognostic markers such as VLA-1 and VLA-5. The xenografts provide good models for further study of metastatic processes as well as for evaluation of alternative treatment modalities including new pharmaceutical drugs and gene therapeutic targeting using tissue-specific gene regulatory elements for gene targeting." @default.
• W2022356742 created "2016-06-24" @default.
• W2022356742 creator A5006740586 @default.
• W2022356742 creator A5011184807 @default.
• W2022356742 creator A5015081490 @default.
• W2022356742 creator A5031958344 @default.
• W2022356742 creator A5034365278 @default.
• W2022356742 creator A5037411180 @default.
• W2022356742 creator A5061846850 @default.
• W2022356742 date "1996-07-01" @default.
• W2022356742 modified "2023-10-06" @default.
• W2022356742 title "Metastatic potential of human melanoma cells in nude mice - characterisation of phenotype, cytokine secretion and tumour-associated antigens" @default.
• W2022356742 cites W1482551393 @default.
• W2022356742 cites W1568700088 @default.
• W2022356742 cites W1599440804 @default.
• W2022356742 cites W1644644959 @default.
• W2022356742 cites W175724447 @default.
• W2022356742 cites W1844290320 @default.
• W2022356742 cites W1972071707 @default.
• W2022356742 cites W1973089244 @default.
• W2022356742 cites W1976451392 @default.
• W2022356742 cites W1977273255 @default.
• W2022356742 cites W1980029742 @default.
• W2022356742 cites W2006987944 @default.
• W2022356742 cites W2016420128 @default.
• W2022356742 cites W2035209084 @default.
• W2022356742 cites W2037588602 @default.
• W2022356742 cites W2045944156 @default.
• W2022356742 cites W2048408428 @default.
• W2022356742 cites W2059776541 @default.
• W2022356742 cites W2071034864 @default.
• W2022356742 cites W2078972442 @default.
• W2022356742 cites W2088342139 @default.
• W2022356742 cites W2088913796 @default.
• W2022356742 cites W2115636784 @default.
• W2022356742 cites W2116161064 @default.
• W2022356742 cites W2120858407 @default.
• W2022356742 cites W2130180403 @default.
• W2022356742 cites W2130185552 @default.
• W2022356742 cites W2145108148 @default.
• W2022356742 cites W2146600597 @default.
• W2022356742 cites W2150409289 @default.
• W2022356742 cites W2151617146 @default.
• W2022356742 cites W2154298769 @default.
• W2022356742 cites W2156889170 @default.
• W2022356742 cites W2159392689 @default.
• W2022356742 cites W2163410470 @default.
• W2022356742 cites W2169052398 @default.
• W2022356742 cites W2410946697 @default.
• W2022356742 cites W2414333822 @default.
• W2022356742 cites W1508296497 @default.
• W2022356742 cites W2425395981 @default.
• W2022356742 doi "https://doi.org/10.1038/bjc.1996.337" @default.
• W2022356742 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2074587" @default.
• W2022356742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8688321" @default.
• W2022356742 hasPublicationYear "1996" @default.
• W2022356742 type Work @default.
• W2022356742 sameAs 2022356742 @default.
• W2022356742 citedByCount "43" @default.
• W2022356742 countsByYear W20223567422012 @default.
• W2022356742 countsByYear W20223567422014 @default.
• W2022356742 countsByYear W20223567422015 @default.
• W2022356742 countsByYear W20223567422016 @default.
• W2022356742 countsByYear W20223567422017 @default.
• W2022356742 countsByYear W20223567422020 @default.
• W2022356742 countsByYear W20223567422022 @default.
• W2022356742 crossrefType "journal-article" @default.
• W2022356742 hasAuthorship W2022356742A5006740586 @default.
• W2022356742 hasAuthorship W2022356742A5011184807 @default.
• W2022356742 hasAuthorship W2022356742A5015081490 @default.
• W2022356742 hasAuthorship W2022356742A5031958344 @default.
• W2022356742 hasAuthorship W2022356742A5034365278 @default.
• W2022356742 hasAuthorship W2022356742A5037411180 @default.
• W2022356742 hasAuthorship W2022356742A5061846850 @default.
• W2022356742 hasBestOaLocation W20223567422 @default.
• W2022356742 hasConcept C121608353 @default.
• W2022356742 hasConcept C126322002 @default.
• W2022356742 hasConcept C142724271 @default.
• W2022356742 hasConcept C203014093 @default.
• W2022356742 hasConcept C2776232967 @default.
• W2022356742 hasConcept C2776256026 @default.
• W2022356742 hasConcept C2777658100 @default.
• W2022356742 hasConcept C2778690821 @default.
• W2022356742 hasConcept C2779013556 @default.
• W2022356742 hasConcept C2780849966 @default.
• W2022356742 hasConcept C502942594 @default.
• W2022356742 hasConcept C54355233 @default.
• W2022356742 hasConcept C71924100 @default.
• W2022356742 hasConcept C81885089 @default.
• W2022356742 hasConcept C86803240 @default.
• W2022356742 hasConceptScore W2022356742C121608353 @default.
• W2022356742 hasConceptScore W2022356742C126322002 @default.
• W2022356742 hasConceptScore W2022356742C142724271 @default.
• W2022356742 hasConceptScore W2022356742C203014093 @default.
• W2022356742 hasConceptScore W2022356742C2776232967 @default.
• W2022356742 hasConceptScore W2022356742C2776256026 @default.
• W2022356742 hasConceptScore W2022356742C2777658100 @default.
• W2022356742 hasConceptScore W2022356742C2778690821 @default.

• next